We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+23.8%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$376M
AUM Growth
+$23.8M
Cap. Flow
-$13.2M
Cap. Flow %
-3.51%
Top 10 Hldgs %
36.6%
Holding
101
New
12
Increased
44
Reduced
25
Closed
20

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$9.17M
2
PCVX icon
Vaxcyte
PCVX
+$6.2M
3
UTHR icon
United Therapeutics
UTHR
+$4.65M
4
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$4.54M
5
BIIB icon
Biogen
BIIB
+$4.3M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$11.2M
2
WAT icon
Waters Corp
WAT
+$5.96M
3
RCM
R1 RCM Inc. Common Stock
RCM
+$5.16M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$4.24M
5
IQV icon
IQVIA
IQV
+$4.02M

Sector Composition

Rank Sector Weight
1 Healthcare 98.13%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$23.1B
$28M 7.46%
100,702
+18,432
+22% +$4.65M
BSX icon
2
Boston Scientific
BSX
$71.5B
$17M 4.53%
367,933
+20,146
+6% +$872K
UNH icon
3
UnitedHealth
UNH
$370B
$14.7M 3.92%
27,742
+101
+0.4% +$53.5K
NBIX icon
4
Neurocrine Biosciences
NBIX
$16.6B
$13.9M 3.7%
116,333
-1,067
-0.9% -$125K
LLY icon
5
Eli Lilly
LLY
$1.06T
$12.6M 3.35%
34,438
-847
-2% -$300K
VRNA
6
DELISTED
Verona Pharma
VRNA
$10.8M 2.88%
414,448
+91,175
+28% +$1.21M
SGEN
7
DELISTED
Seagen Inc. Common Stock
SGEN
$10.5M 2.8%
81,854
+9,457
+13% +$1.22M
HAE icon
8
Haemonetics
HAE
$4B
$10.4M 2.77%
132,378
+16,581
+14% +$1.33M
DHR icon
9
Danaher
DHR
$144B
$10.2M 2.71%
43,307
-16,484
-28% -$3.82M
XENE icon
10
Xenon Pharmaceuticals
XENE
$6.12B
$9.29M 2.47%
235,491
+12,894
+6% +$470K
HUM icon
11
Humana
HUM
$46.2B
$8.93M 2.38%
+17,439
New +$9.17M
CTIC
12
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$8.47M 2.25%
1,408,642
+198,497
+16% +$1.08M
PCVX icon
13
Vaxcyte
PCVX
$8.64B
$7.58M 2.02%
+158,048
New +$6.2M
DXCM icon
14
DexCom
DXCM
$32B
$7.1M 1.89%
62,730
+22,372
+55% +$2.46M
CNCE
15
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$7.03M 1.87%
1,203,484
+65,897
+6% +$347K
STRO icon
16
Sutro Biopharma
STRO
$421M
$7M 1.86%
86,598
+17,864
+26% +$1.24M
ELV icon
17
Elevance Health
ELV
$85.5B
$6.31M 1.68%
12,296
-4,900
-28% -$2.49M
THC icon
18
Tenet Healthcare
THC
$21.1B
$6.17M 1.64%
126,505
-32,519
-20% -$1.5M
KROS icon
19
Keros Therapeutics
KROS
$221M
$6.09M 1.62%
126,790
+26,863
+27% +$1.25M
CDMO
20
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$5.9M 1.57%
428,268
+23,450
+6% +$359K
DCPH
21
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$5.65M 1.51%
344,920
+43,028
+14% +$700K
MNKD icon
22
MannKind Corp
MNKD
$1.32B
$5.43M 1.45%
1,031,109
+106,130
+11% +$434K
IONS icon
23
Ionis Pharmaceuticals
IONS
$9.4B
$5.33M 1.42%
141,115
-100,830
-42% -$4.24M
PODD icon
24
Insulet
PODD
$9.79B
$5.31M 1.41%
18,042
+988
+6% +$272K
ESPR
25
DELISTED
Esperion Therapeutics
ESPR
$5.13M 1.36%
822,784
+526,403
+178% +$3.76M
1
2 3 4 5

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
SFO
Stokes Family Office New Orleans, Louisiana $969M AUM 19.6% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return

Parkman Healthcare Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Parkman Healthcare Partners held 101 positions worth $376M, up 6.8% from $352M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parkman Healthcare Partners withdrew a net $13.2M in Q4 2022, closing 20 positions and reducing 25 holdings. Its most notable exit was CVS Health, an estimated $11.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 96% a quarter earlier, followed by Industrials.

Against the trend, Parkman Healthcare Partners opened a new position in Humana worth $8.93M.

  • Parkman Healthcare Partners's largest Q4 2022 buy was Humana: 17,439 shares worth $8.93M.
  • Parkman Healthcare Partners added most to United Therapeutics in Q4 2022, an estimated $4.65M increase.
  • Parkman Healthcare Partners's biggest Q4 2022 reduction was Waters Corp, cutting an estimated $5.96M.
  • Parkman Healthcare Partners fully exited CVS Health in Q4 2022, selling an estimated $11.2M.
  • Parkman Healthcare Partners's ten largest holdings make up 37% of its $376M portfolio in Q4 2022.
  • Parkman Healthcare Partners opened 12 new positions and closed 20 in Q4 2022.
  • Parkman Healthcare Partners's portfolio value rose 6.8% quarter-over-quarter to $376M.

Based on Parkman Healthcare Partners's 13F filing for Q4 2022, filed 13 Feb 2023.